Sessioni Comunicazioni Orali
PHARMACOECONOMICS, PHARMACOEPIDEMIOLOGY & PHARMACOVIGILANCE II
28/10/2017 / 9.00 - 11.00
| 104 | Drug interactions with levothyroxine therapy: tablets versus oral liquid formulations 1)Lapi FL. 2)Bianchini EB. 3)Guglielmi VG. 4)Cricelli CI. 5)Bellia AB. 6)Cricelli CC. |
| 105 | The high price of anticancer drugs does not reflect therapeutic benefit in Italy 1)Trotta F. 2)Mayer F. 3)Barone-adesi F. 4)Esposito I. 5)Punreddy R. 6)Da cas R. 7)Traversa G. 8)Perrone F. 9)Martini N. 10)Addis A. |
| 106 | Real-world evidence on the risk of acute cardiovascular events among elderly hypertensive patients treated with calcium channel blockers in secondary cardiovascular prevention 1)Bettiol A. 2)Lucenteforte E. 3)Vannacci A. 4)Lombardi N. 5)Onder G. 6)Agabiti N. 7)Vitale C. 8)Trifirò G. 9)Corrao G. 10)Roberto G. 11)Mugelli A. 12)Chinellato A. |
| 107 | ADHERENCE TO THERAPY WITH DIFFERENT SECOND-LINE HYPOGLYCAEMIC DRUGS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS 1)Galimberti F. 2)Casula M. 3)Mozzanica F. 4)Scotti L. 5)Pirillo A. 6)Corrao G. 7)Tragni E. 8)Catapano AL. |
| 108 | REAL WORLD DATA ON BIOLOGICAL DRUGS USED IN ONCOLOGY: A 5 YEARS PICTURE' IN SOUTHERN ITALY 1)Lucchesi S.. 2)Marcianò I.. 3)Randazzo M.. 4)Panagia P.. 5)Intelisano R.. 6)Sgroi C.. 7)Santarpia M.. 8)Adamo V.. 9)Franchina T.. 10)Spina E.. 11)Trifirò G.. |
| 109 | COMPARATIVE EFFICACY OF ANTIEPILEPTIC DRUGS IN CHILDREN AND ADOLESCENTS: A NETWORK META-ANALYSIS 1)Lucenteforte E. 2)Rosati A. 3)Ilvento L. 4)Crescioli G. 5)Mcgreevy KS. 6)Pugi A. 7)Virgili G. 8)Mugelli A. 9)De masi S. 10)Guerrini R. |
| 110 | Effect of Chronic Kidney Diseases on Mortality in Patients Treated with Digoxin for Non-Valvular Atrial Fibrillation: A Nationwide Register-Based Retrospective Cohort Study. 1)Mascolo A. 2)Sessa M. 3)Andersen M. 4)Rosano G. 5)Rossi F. 6)Capuano A. 7)Torp-pedersen C. |
| 111 | Un-Suggested Prescriptions of Non-Cardio-Selective Beta-Blockers for Heart Failure in Patients with Concurrent Chronic Obstructive Pulmonary Disease. 1)Sessa M. 2)Mascolo A. 3)Mortensen R. 4)Andersen M. 5)Rosano G. 6)Capuano A. 7)Rossi F. 8)Gislason G. 9)Enghusen-poulsen H. 10)Torp-pedersen C. |
| 112 | IMMUNE RELATED ADVERSE EVENTS ASSOCIATED WITH IMMUNE CHECKPOINTS INHIBITORS: A SYSTEMATIC REVIEW AND META-ANALYSIS 1)Spini A.. 2)Moscatelli V.. 3)Cucherat M.. 4)Roberto G.. 5)Gini R.. 6)Raschi E.. 7)Ziche M.. 8)Salvo F.. |